Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 9, 2011

 

Drug Name

 Review Type Class Manufacturer
Pradaxa New Drug Initial Review Direct Thrombin Inhibitor Boehringer Ingelheim
Veregen New Drug Initial Review Topical Genital Wart � HPV Treatment Agent PharmaDerm
Latuda New Drug Initial Review Antipsychotic Sunovion
Kapvay New Drug Initial Review Alpha-2 Adrenergic Agent Shionogi Pharma
Fanapt New Drug Appeal Atypical Antipsychotic Novartis
Pegasys PDL Appeal Hepatitis B and C Agent Genentech